• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激肽释放酶 5 促进口腔鳞状细胞癌中桥粒芯糖蛋白 1 的裂解和细胞间黏附的丧失。

Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.

机构信息

Department of Pathology and Anatomical Science, University of Missouri School of Medicine, Columbia, Missouri 65212, USA.

出版信息

J Biol Chem. 2011 Mar 18;286(11):9127-35. doi: 10.1074/jbc.M110.191361. Epub 2010 Dec 16.

DOI:10.1074/jbc.M110.191361
PMID:21163944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3059049/
Abstract

Oral squamous cell carcinoma (OSCC) ranks among the top 8 causes of cancer death worldwide, with only a 60% 5-year survival rate, highlighting the need for discovery of novel biomarkers and therapeutic targets. We have previously reported that expression of a panel of serine proteinase kallikreins (KLK 5, 7, 8, and 10) is correlated with formation of more aggressive OSCC tumors in a murine orthotopic OSCC model and is elevated in human OSCC. Current studies focus on understanding the potential role of KLK5 in OSCC progression. In initial studies, KLK levels in malignant OSCC cells (SCC25) were compared with cells from normal oral mucosa (OKF/6) and pre-malignant oral keratinocytes (pp126) using qPCR. A marked elevation of all KLKs was observed in aggressive SCC25 cells relative to OKF/6 cells. In normal skin, KLKs are involved in desquamation during epidermal differentiation via proteolytic cleavage of the desmosomal cadherin component desmoglein 1 (Dsg1). As loss of cell-cell cohesion is prevalent in tumor metastasis, Dsg1 integrity was evaluated. Results show that SCC25 cells exhibit cleavage of Dsg1, which is blocked by proteinase inhibitor treatment as well as by siRNA silencing of KLK5 expression. Furthermore, cell-cell aggregation assays demonstrate that silencing of KLK5 enforces cell-cell adhesion; conversely, overexpression of KLK5 in normal oral mucosal cells (OKF/6) enhances cell dispersal. These data suggest that KLK5 may promote metastatic dissemination of OSCC by promoting loss of junctional integrity through cleavage of desmoglein 1.

摘要

口腔鳞状细胞癌(OSCC)是全球癌症死亡的前 8 大原因之一,其 5 年生存率仅为 60%,这突出表明需要发现新的生物标志物和治疗靶标。我们之前曾报道过,一组丝氨酸蛋白酶激肽原(KLK5、7、8 和 10)的表达与在鼠原位 OSCC 模型中形成侵袭性更高的 OSCC 肿瘤相关,并且在人 OSCC 中升高。目前的研究集中在理解 KLK5 在 OSCC 进展中的潜在作用。在初步研究中,使用 qPCR 比较了恶性 OSCC 细胞(SCC25)与正常口腔粘膜细胞(OKF/6)和前恶性口腔角质形成细胞(pp126)中的 KLK 水平。与 OKF/6 细胞相比,侵袭性 SCC25 细胞中所有 KLK 的水平均明显升高。在正常皮肤中,KLKs 通过对桥粒钙粘蛋白成分桥粒蛋白 1(Dsg1)的蛋白水解切割参与表皮分化中的脱屑。由于肿瘤转移中普遍存在细胞-细胞黏附丧失,因此评估了 Dsg1 的完整性。结果表明,SCC25 细胞显示出 Dsg1 的裂解,该裂解可通过蛋白酶抑制剂处理以及 KLK5 表达的 siRNA 沉默来阻断。此外,细胞-细胞聚集测定表明 KLK5 的沉默增强了细胞-细胞黏附;相反,在正常口腔粘膜细胞(OKF/6)中过表达 KLK5 增强了细胞分散。这些数据表明 KLK5 可能通过切割桥粒蛋白 1 促进 OSCC 的转移扩散,从而破坏连接完整性。

相似文献

1
Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.激肽释放酶 5 促进口腔鳞状细胞癌中桥粒芯糖蛋白 1 的裂解和细胞间黏附的丧失。
J Biol Chem. 2011 Mar 18;286(11):9127-35. doi: 10.1074/jbc.M110.191361. Epub 2010 Dec 16.
2
Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.多种激肽释放酶(KLK 5、7、8和10)在口腔鳞状细胞癌中的表达
Histol Histopathol. 2009 Feb;24(2):197-207. doi: 10.14670/HH-24.197.
3
Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.蛋白酶激活受体-2(PAR-2)介导的核因子κB激活抑制口腔鳞状细胞癌中炎症相关的肿瘤抑制性微小RNA
J Biol Chem. 2016 Mar 25;291(13):6936-45. doi: 10.1074/jbc.M115.692640. Epub 2016 Feb 2.
4
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.持续的激肽释放酶 5 激活可诱导特应性皮炎样皮肤结构,而不依赖于 PAR2 活性。
J Allergy Clin Immunol. 2017 Nov;140(5):1310-1322.e5. doi: 10.1016/j.jaci.2017.01.025. Epub 2017 Feb 24.
5
hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.hsa-miR-485-5p 通过靶向PAK1逆转口腔舌鳞状细胞癌中的上皮-间质转化并促进顺铂诱导的细胞死亡。
Int J Mol Med. 2017 Jul;40(1):83-89. doi: 10.3892/ijmm.2017.2992. Epub 2017 May 16.
6
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.多种组织激肽释放酶丝氨酸蛋白酶在表皮脱屑中的潜在作用。
J Biol Chem. 2007 Feb 9;282(6):3640-52. doi: 10.1074/jbc.M607567200. Epub 2006 Dec 11.
7
Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.唾液 KLK5 和 uPA 是 OLK 和 OLP 恶性转化的潜在生物标志物。
Cancer Biomark. 2021;31(4):317-328. doi: 10.3233/CBM-203105.
8
Clinical significance of kallikrein-related peptidase-4 in oral cancer.组织激肽释放酶相关肽酶-4在口腔癌中的临床意义
Anticancer Res. 2015 Apr;35(4):1861-6.
9
Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner.桥粒芯糖蛋白 1 通过以 Erbin 依赖的方式抑制 EGFR/Erk 信号来调节侵袭伪足。
Mol Cancer Res. 2019 May;17(5):1195-1206. doi: 10.1158/1541-7786.MCR-18-0048. Epub 2019 Jan 17.
10
SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.作为 Netherton 综合征模型系统的人皮肤器官培养中的 SPINK5 基因敲低:丝氨酸蛋白酶激肽释放酶 5 和激肽释放酶 7 基因抑制的影响
Exp Dermatol. 2014 Jul;23(7):524-6. doi: 10.1111/exd.12451.

引用本文的文献

1
The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology.癌症中的丝氨酸蛋白酶抑制剂Kazal型相关肽(SPINK)蛋白家族:在肿瘤进展、治疗抗性和精准肿瘤学中的新作用
Pharmaceuticals (Basel). 2025 Aug 13;18(8):1194. doi: 10.3390/ph18081194.
2
Towards propagation of epidermal cells for wound repair: glass, as cell culture substrate, enhances proliferation and migration of human keratinocytes.用于伤口修复的表皮细胞增殖研究:玻璃作为细胞培养底物可增强人角质形成细胞的增殖和迁移能力。
Front Bioeng Biotechnol. 2025 Mar 20;13:1547044. doi: 10.3389/fbioe.2025.1547044. eCollection 2025.
3
Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.嗜酸性粒细胞性食管炎:免疫机制与治疗靶点。
Clin Exp Allergy. 2022 Oct;52(10):1142-1156. doi: 10.1111/cea.14196. Epub 2022 Jul 19.
4
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.激肽释放酶相关肽酶重塑肿瘤微环境。
Nat Rev Cancer. 2022 Apr;22(4):223-238. doi: 10.1038/s41568-021-00436-z. Epub 2022 Jan 31.
5
Desmosomal Cadherins in Health and Disease.桥粒黏附蛋白在健康与疾病中的作用
Annu Rev Pathol. 2022 Jan 24;17:47-72. doi: 10.1146/annurev-pathol-042320-092912. Epub 2021 Aug 23.
6
Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer.KLK8的上调预示着胰腺癌的预后不良。
Front Oncol. 2021 Jul 30;11:624837. doi: 10.3389/fonc.2021.624837. eCollection 2021.
7
Paradoxical Roles of Desmosomal Components in Head and Neck Cancer.桥粒成分在头颈部癌症中的矛盾作用。
Biomolecules. 2021 Jun 20;11(6):914. doi: 10.3390/biom11060914.
8
Kallikreins: Essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease.激肽释放酶:在稳态、修复和疾病过程中调节皮肤微环境的重要表皮信使。
Matrix Biol Plus. 2019 Nov 21;6-7:100019. doi: 10.1016/j.mbplus.2019.100019. eCollection 2020 May.
9
Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma.激肽释放酶5(KLK5)与淋巴上皮Kazal型相关抑制剂(LEKTI)的相对表达与口腔鳞状细胞癌的侵袭性相关。
Transl Oncol. 2021 Jan;14(1):100970. doi: 10.1016/j.tranon.2020.100970. Epub 2020 Nov 28.
10
Long noncoding RNA HEIH depletion depresses esophageal carcinoma cell progression by upregulating microRNA-185 and downregulating KLK5.长链非编码 RNA HEIH 耗竭通过上调 microRNA-185 和下调 KLK5 抑制食管癌细胞的进展。
Cell Death Dis. 2020 Nov 22;11(11):1002. doi: 10.1038/s41419-020-03170-w.

本文引用的文献

1
Correlation of the expression of human kallikrein-related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma.人激肽释放酶相关肽酶 4 和 7 的表达与口腔鳞状细胞癌预后的相关性。
Head Neck. 2011 Apr;33(4):566-72. doi: 10.1002/hed.21496.
2
Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.丝氨酸蛋白酶组织抑制剂(matriptase)在 Netherton 综合征小鼠模型中启动表皮前激肽释放酶的激活和疾病发生。
Nat Genet. 2010 Aug;42(8):676-83. doi: 10.1038/ng.629. Epub 2010 Jul 25.
3
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
4
Molecules of cell adhesion and extracellular matrix proteolysis in oral squamous cell carcinoma.口腔鳞状细胞癌中细胞黏附分子和细胞外基质蛋白水解。
Histol Histopathol. 2010 Jul;25(7):917-32. doi: 10.14670/HH-25.917.
5
Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.尿激酶型纤溶酶原激活物受体/α3β1 整联蛋白信号、基因表达改变与口腔肿瘤进展。
Mol Cancer Res. 2010 Feb;8(2):145-58. doi: 10.1158/1541-7786.MCR-09-0045. Epub 2010 Feb 9.
6
Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.类固醇类激肽释放酶:前列腺特异性抗原和扩展激肽释放酶基因座的结构、功能和激素调节。
Endocr Rev. 2010 Aug;31(4):407-46. doi: 10.1210/er.2009-0034. Epub 2010 Jan 26.
7
Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.多种激肽释放酶(KLK 5、7、8和10)在口腔鳞状细胞癌中的表达
Histol Histopathol. 2009 Feb;24(2):197-207. doi: 10.14670/HH-24.197.
8
Transcriptomic dissection of tongue squamous cell carcinoma.舌鳞状细胞癌的转录组剖析
BMC Genomics. 2008 Feb 6;9:69. doi: 10.1186/1471-2164-9-69.
9
Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.I期和II期口腔舌鳞状细胞癌患者的预后较差。
Cancer. 2008 Jan 15;112(2):345-51. doi: 10.1002/cncr.23183.
10
Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity.口腔鳞状细胞癌中的尿激酶型纤溶酶原激活剂(uPA)及其受体(uPAR)
Biochem J. 2007 Oct 15;407(2):153-9. doi: 10.1042/BJ20071037.